NCT00881426View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Healthy
Interventions
DRUG

Cefprozil 500 mg Tablets (Sandoz GmbH)

DRUG

Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00881426 - To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter